Politics + Legalization

FDA Targets Small Vape Companies With Permanent Injunctions

On October 18, the Food and Drug Administration (FDA) and the Department of Justice (DOJ) announced that they had filed…

October 19, 2022

Hyde Rejections: The FDA’s Rush to Capitalize on New Youth Vaping Data

On October 6, the day the Centers for Disease Control and Prevention (CDC) released new data showing a modest uptick…

October 18, 2022

Brazil Harm Reduction Faces an Uphill Battle, Even If Bolsonaro Is Ousted

Many people, myself included, were sure that President Jair Bolsonaro’s misrule would end in Brazil's first round of elections, held…

October 13, 2022

The People Left Behind by Biden’s Cannabis Pardons

President Joe Biden’s surprise marijuana pardon action on October 6 has been widely praised as an important step toward righting…

October 11, 2022

Biden Pardons All Federal Cannabis Possession Convictions

In a historic moment for drug policy reform in the United States, President Joe Biden announced on October 6 that…

October 6, 2022

Australia’s Experiment With Prescription-Only Vapes Has Failed

The Australian government’s medical, prescription-only model for nicotine vaping was introduced on October 1, 2021, and has been a resounding…

September 30, 2022

Amid Veteran Suicide Crisis, First US Pilot Program for MDMA and Psilocybin Treatment Moves Forward

On September 29, advocates spoke before Congress about the crisis of veteran suicide and the urgent need for accessible, affordable…

September 29, 2022

FDA Enlists Ex-FDA Leadership for Independent Review of Tobacco Center

On September 21, a two-month independent evaluation of the Food and Drug Administration’s tobacco center commenced amid concern from tobacco…

September 28, 2022

Vape Taxes a Great Way to Encourage Smoking, Researchers Show

A new paper published in the Journal of Health Economics suggests that burdensome taxes on vaping products lead to an…

September 26, 2022

FDA Exempts Harm Reduction From Biggest Naloxone Access Restrictions

On September 22, the Food and Drug Administration announced that harm reduction naloxone suppliers are exempt from wholesale pharmaceutical distribution…

September 26, 2022